“Efficacy and safety of 48 weeks of guselkumab for patients with Crohn’s disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial”
Matthew Vincent, MBBS
&
“Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial”
Qianli Wang, MD, PhD
Please Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for Zoom Details